Effects of Hydrogen-rich Water Consumption on Transient Fatigue During an Official Football Match: Protocol for a Randomised, Double-blind, Placebo-controlled, Parallel-group Trial
HRW-FOOTBALL
2 other identifiers
interventional
30
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether drinking hydrogen-rich water can reduce fatigue and help football players maintain high-intensity physical activity during an official football match. The study will include 30 male football players competing in the second and third tiers of the Czech national football league system. Participants will be randomly assigned to drink either hydrogen-rich water or placebo water. Neither the players nor the researchers conducting the assessments will know which type of water each participant receives until the study has been completed. Participants will begin drinking the assigned water 72 hours before the match and will continue drinking it on match day. Players' physical activity and heart rate will be monitored throughout the match. The main outcome will be the distance covered at high intensity during consecutive 5-minute periods of the match. Repeated-sprint ability, jumping performance, and perceived muscle soreness will also be assessed before and after the match. The study will compare the hydrogen-rich water and placebo groups to determine whether hydrogen-rich water helps players maintain high-intensity activity during the match and reduces short-term fatigue after the match.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2027
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2026
CompletedFirst Posted
Study publicly available on registry
October 2, 2026
CompletedStudy Start
First participant enrolled
January 20, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2027
Study Completion
Last participant's last visit for all outcomes
June 10, 2027
October 2, 2026
September 1, 2026
2 months
September 28, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
High-Intensity Distance During Match Play
High-intensity distance (HID), defined as the distance covered at running speeds \>14.4 km·h-¹, will be measured continuously during an official football match using a 10-Hz global positioning system (GPS; Vector S7, Catapult Sports, Melbourne, Australia). HID will be quantified in metres for consecutive 5-minute intervals throughout match play. The temporal pattern of HID will be compared between the hydrogen-rich water and placebo groups.
During the official football match (consecutive 5-minute intervals, up to 90 minutes)
Secondary Outcomes (6)
Total Distance During Match Play
During the official football match (consecutive 5-minute intervals, up to 90 minutes)
PlayerLoad During Match Play
During the official football match (consecutive 5-minute intervals, up to 90 minutes)
Top Speed During Match Play
During the official football match (up to 90 minutes)
Heart Rate During Match Play
During the official football match (consecutive 5-minute intervals, up to 90 minutes)
Repeated-Sprint Ability
Pre-match and immediately post-match
- +1 more secondary outcomes
Study Arms (2)
Hydrogen-Rich Water (HRW)
EXPERIMENTALParticipants assigned to this arm will consume hydrogen-rich water (HRW) containing 1.2-1.4 ppm dissolved molecular hydrogen. Participants will consume 1,260 mL (three 420-mL packs) at 72, 48, and 24 hours before the official football match, 840 mL (two 420-mL packs) after the pre-match warm-up, and 420 mL (one 420-mL pack) during the first half of the match.
Placebo water
PLACEBO COMPARATORParticipants assigned to this arm will consume placebo water containing no dissolved molecular hydrogen (0.0 ppm). The placebo will be provided in visually identical 420-mL packs and administered according to the same supplementation schedule as the HRW intervention: 1,260 mL at 72, 48, and 24 hours before the official football match, 840 mL after the pre-match warm-up, and 420 mL during the first half of the match.
Interventions
Hydrogen-rich water containing 1.2-1.4 ppm dissolved molecular hydrogen (H₂), supplied in gas-tight 420-mL plastic-aluminium packs. Participants will consume 1,260 mL at 72, 48, and 24 hours before the official football match, 840 mL after the pre-match warm-up, and 420 mL during the first half of the match, corresponding to a total intervention volume of 5,040 mL per participant.
Placebo water containing no dissolved molecular hydrogen (0.0 ppm), supplied in visually identical 420-mL plastic-aluminium packs. The placebo will be administered according to the same volume and timing schedule as the hydrogen-rich water intervention, corresponding to a total intervention volume of 5,040 mL per participant.
Eligibility Criteria
You may qualify if:
- Male football players aged 18 years or older.
- Currently competing in the second or third tier of the Czech national football league system.
- At least 15 years of football experience.
- Participation in at least four team training sessions per week in addition to regular competitive matches.
- Free from injury or other medical conditions that could limit participation in training, testing, or match play.
- Willing and able to provide written informed consent.
You may not qualify if:
- Illness during the three weeks preceding the baseline assessment.
- Injury during the three weeks preceding the baseline assessment.
- Any injury or medical condition that could limit participation in training, testing, or match play.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Palacky Universitylead
- University of Splitcollaborator
Related Publications (1)
Aoki, K., Nakao, A., Adachi, T., Matsui, Y., & Miyakawa, S. (2012). Pilot study: Effects of drinking hydrogen-rich water on muscle fatigue caused by acute exercise in elite athletes. Medical Gas Research, 2, 12. https://doi.org/10.1186/2045-9912-2-12 Bangsbo, J., Mohr, M., & Krustrup, P. (2006). Physical and metabolic demands of training and match-play in the elite football player. J. Sports Sci., 24(7), 665-674. https://doi.org/10.1080/02640410500482529 Beato, M., Coratella, G., Schena, F., & Hulton, A. T. (2017). Evaluation of the external and internal workload in female futsal players. Biology of Sport, 3, 227-231. https://doi.org/10.5114/biolsport.2017.65998 Botek, M., Krejci, J., McKune, A. J., Sladeckova, B., & Naumovski, N. (2019). Hydrogen Rich Water Improved Ventilatory, Perceptual and Lactate Responses to Exercise. INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 40(14), 879-885. https://doi.org/10.1055/a-0991-0268 Botek, M., Krejčí, J., McKune, A., Valenta, M., & Sládečková, B. (2022). Hydrogen Rich Water Consumption Positively Affects Muscle Performance, Lactate Response, and Alleviates Delayed Onset of Muscle Soreness After Resistance Training. The Journal of Strength & Conditioning Research, 36(10). https://journals.lww.com/nsca-jscr/Fulltext/2022/10000/Hydrogen_Rich_Water_Consumption_Positively_Affects.15.aspx Bradley, P. S., & Noakes, T. D. (2013). Match running performance fluctuations in elite soccer: Indicative of fatigue, pacing or situational influences? Journal of Sports Sciences, 31(15), 1627-1638. https://doi.org/10.1080/02640414.2013.796062 Brownstein, C. G., Dent, J. P., Parker, P., Hicks, K. M., Howatson, G., Goodall, S., & Thomas, K. (2017). Etiology and Recovery of Neuromuscular Fatigue following Competitive Soccer Match-Play. Frontiers in Physiology, 8. https://doi.org/10.3389/fphys.2017.00831 Chan, A.-W., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., But
RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Coaches and the statistician performing the primary analysis will also be masked to treatment allocation. The allocation code will be held exclusively by the manufacturer and will not be disclosed until the database has been finalised and the primary statistical analysis has been completed.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Palacký University Olomouc
Study Record Dates
First Submitted
September 28, 2026
First Posted
October 2, 2026
Study Start (Estimated)
January 20, 2027
Primary Completion (Estimated)
March 15, 2027
Study Completion (Estimated)
June 10, 2027
Last Updated
October 2, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning immediately following publication of the primary study results, with no planned end date.
- Access Criteria
- De-identified individual participant data underlying the results reported in the primary publication, together with the study protocol, will be publicly available through the Open Science Framework (OSF). The data will be accessible to researchers and other interested users without the need for individual approval or submission of a formal data request.
De-identified individual participant data underlying the results reported in the primary publication will be shared. The shared dataset will include participant characteristics, treatment allocation, match external- and internal-load variables, repeated-sprint ability, countermovement jump performance, and perceived lower-limb muscle soreness. Data will be de-identified to protect participant confidentiality.